Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors of Secondary Cardiovascular Events

Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors of Secondary Cardiovascular Events

Ischemic event in one arterial territory increases the risk of a subsequent ischemic event. Circulating microRNAs (miRs) emerge as a potential clinical tool to assess risk of subsequent atherothrombotic events such as cardiovascular death (CVD), myocardial infarction (MI) and ischemic stroke (IS). I...

Full description

Bibliographic Details
Main Authors:	Rafał Badacz, Paweł Kleczyński, Jacek Legutko, Krzysztof Żmudka, Jacek Gacoń, Tadeusz Przewłocki, Anna Kabłak-Ziembicka
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Biomedicines
Subjects:	acute ischemic event biomarkers cardiovascular events cardiovascular death carotid artery lesions coronary artery disease
Online Access:	https://www.mdpi.com/2227-9059/9/8/1055

Similar Items

MicroRNA-134-5p and the Extent of Arterial Occlusive Disease Are Associated with Risk of Future Adverse Cardiac and Cerebral Events in Diabetic Patients Undergoing Carotid Artery Stenting for Symptomatic Carotid Artery Disease
by: Rafał Badacz, et al.
Published: (2022-04-01)

Diagnostic value of cardiac miR-126-5p, miR-134-5p, and miR-499a-5p in coronary artery disease-induced sudden cardiac death
by: Linfeng Li, et al.
Published: (2022-08-01)

Bioinformatics analysis of the common targets of miR-223-3p, miR-122-5p, and miR-93-5p in polycystic ovarian syndrome
by: Liping Zou, et al.
Published: (2023-02-01)

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
by: Alja Zottel, et al.
Published: (2020-11-01)

Normospermic Patients Infected With Ureaplasma parvum: Role of Dysregulated miR-122-5p, miR-34c-5, and miR-141-3p
by: Marilena Galdiero, et al.
Published: (2024-01-01)

Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer
by: Tommaso Mazza, et al.
Published: (2020-02-01)

Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as Potential Biomarkers in Human Liver Transplantation Follow-Up
by: Cristina Morsiani, et al.
Published: (2023-02-01)

MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially expressed in hypertensive patients with left ventricular hypertrophy
by: C.M. Kaneto, et al.
Published: (2017-10-01)

Physical Exercise Modulates miR-21-5p, miR-129-5p, miR-378-5p, and miR-188-5p Expression in Progenitor Cells Promoting Osteogenesis
by: Maria Teresa Valenti, et al.
Published: (2019-07-01)

Clinical Values and Underlying Mechanism Analysis of Serum miR-455-5p in Carotid Artery Stenosis
by: Zhu B, et al.
Published: (2022-05-01)

Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
by: Xulei Huo, et al.
Published: (2023-11-01)

Increased expression of miR-224-5p in circulating extracellular vesicles of patients with reduced coronary flow reserve
by: Kreema James, et al.
Published: (2022-07-01)

miR-9-5p, miR-675-5p and miR-138-5p regulate Wnt signalling pathways and strontium-mediated osteogenesis
by: Tianhao Sun, et al.
Published: (2016-10-01)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01)

Association of Serum miR-186-5p With the Prognosis of Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention
by: Zhuoling Li, et al.
Published: (2019-06-01)

LncRNA CFRL aggravates cardiac fibrosis by modulating both miR-3113-5p/CTGF and miR-3473d/FN1 axis
by: Yue Cui, et al.
Published: (2023-10-01)

miR−122−5p Regulates Renal Fibrosis In Vivo
by: Shohei Kaneko, et al.
Published: (2022-12-01)

Homocysteine metabolites inhibit autophagy by upregulating miR-21-5p, miR-155-5p, miR-216-5p, and miR-320c-3p in human vascular endothelial cells
by: Łukasz Witucki, et al.
Published: (2024-03-01)

Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in Oral Squamous Cell Carcinoma: A Potential Biomarkers Panel?
by: Ovidiu Aghiorghiesei, et al.
Published: (2022-04-01)

Increased miR-142 Levels in Plasma and Atherosclerotic Plaques from Peripheral Artery Disease Patients with Post-Surgery Cardiovascular Events
by: Teodora Barbalata, et al.
Published: (2020-12-01)

Evaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma
by: Ata Garajei, et al.
Published: (2022-02-01)

MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer
by: Tamyres Mingorance Carvalho, et al.
Published: (2022-06-01)

Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells
by: Maristella Canovai, et al.
Published: (2023-12-01)

Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p Are Novel Biomarkers for Diagnosis of Acute Myocardial Infarction
by: Sheng Xue, et al.
Published: (2019-02-01)

Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease
by: Gao Wei, et al.
Published: (2012-05-01)

The inverted pattern of circulating miR-221-3p and miR-222-3p associated with isolated low HDL-C phenotype
by: Yuntao Zhou, et al.
Published: (2018-08-01)

Association between Circulating MicroRNAs (miR-21-5p, miR-20a-5p, miR-29b-3p, miR-126-3p and miR-101-3p) and Chronic Allograft Dysfunction in Renal Transplant Recipients
by: Yu-Jen Chen, et al.
Published: (2022-10-01)

Circulating miRNAs Are Associated with the Systemic Extent of Atherosclerosis: Novel Observations for miR-27b and miR-146
by: Tiago Pereira-da-Silva, et al.
Published: (2021-02-01)

miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
by: Srinivas Chava, et al.
Published: (2020-01-01)

Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
by: Frauke G. Heinemann, et al.
Published: (2018-01-01)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
by: Miruna Nemecz, et al.
Published: (2023-09-01)

Plasma-derived exosomal let-7c-5p, miR-335–3p, and miR-652–3p as potential diagnostic biomarkers for stable coronary artery disease
by: Jian Han, et al.
Published: (2023-05-01)

Qualitative and quantitative assessment of sperm miRNAs identifies hsa-miR-9-3p, hsa-miR-30b-5p and hsa-miR-122-5p as potential biomarkers of male infertility and sperm quality
by: Meghali Joshi, et al.
Published: (2022-08-01)

A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients—A Review PART II—Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary Territory
by: Marcin Piechocki, et al.
Published: (2024-03-01)

Characterization of miR-335-5p and miR-335-3p in human osteoarthritic tissues
by: Thomas G. Wilson, et al.
Published: (2023-06-01)

Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation
by: Zhang T, et al.
Published: (2021-04-01)

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
by: Paulina López, et al.
Published: (2018-05-01)

Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease
by: Rachel E. Crossland, et al.
Published: (2021-03-01)

MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction
by: Meyer Elbaz, et al.
Published: (2022-09-01)

Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p
by: Francesca Beretta, et al.
Published: (2022-02-01)